Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study-Reference-Cited by-同舟云学术

Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study

Published:2022-10 Issue:10359 Volume:400 Page:1213-1222
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Wong Carlos K H,Au Ivan C H,Lau Kristy T K,Lau Eric H Y,Cowling Benjamin J,Leung Gabriel M

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients;Jayk Bernal;N Engl J Med,2022

2. Molnupiravir in COVID-19: a systematic review of literature;Singh;Diabetes Metab Syndr,2021

3. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-1: a meta-analysis;Wen;Ann Med,2022

4. A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus;Fischer;Sci Transl Med,2022

5. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19;Hammond;N Engl J Med,2022

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort study;Clinical Microbiology and Infection;2024-10

2. A comprehensive study of SARS-CoV-2 mfigain protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system;PLOS Pathogens;2024-09-11

3. Cardiovascular adverse effects of antiviral therapies for COVID-19: Evidence and plausible mechanisms;Acta Pharmacologica Sinica;2024-09-09

4. Methodological Challenges using Routine Clinical Care Data for Real-World Evidence: a Rapid Review utilizing a systematic literature search and focus group discussion;2024-09-06

5. An overview of the development of pharmacotherapeutics targeting SARS-CoV-2;Drug Discovery Today;2024-09